acute urinary retention


Also found in: Dictionary, Acronyms.

acute urinary retention

A general term for an abrupt cessation of urinary flow, resulting in painful distension of the bladder.

Aetiology
Benign prostatic hyperplasia, neuropathy, constipation, cystitis, urethritis, medications (e.g., anticholinergics, antidepressants, COX-2 inhibitors, amphetamines and opiates).
 
Diagnosis
Urinary flow tests.

Complications
Bladder stones, detrusor muscle atrophy or hypertrophy, bladder diverticula, hydronephrosis.

Management
Urinary catherisation, alpha blockers, 5-alpha-reductase inhibitors, prostate resection.
References in periodicals archive ?
Forty percent of patients continued with a second BTX-A treatment despite acute urinary retention.
These cases were matched with 46,865 men and 9,020 women with COPD who did not develop acute urinary retention and served as control subjects.
Finally, many medications can cause acute urinary retention, including sedatives, antipsychotics, anticholinergics, antihistamines, and analgesics.
The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.
FDA has determined that a Risk Evaluation and Mitigation Strategy (REMS) will be necessary for ezogabine, with the goal of informing healthcare professionals of the risk of urinary retention and the symptoms of acute urinary retention.
PARIS -- The [alpha]-1 blocker alfuzosin prevented overall clinical progression of benign prostatic hyperplasia but had no impact on acute urinary retention in a 2-year, double-blind, placebo-controlled, multinational study that enrolled 1,522 men at high risk of serious outcomes.
BPH causes difficulties with urination associated with aging, such as urination at night, urge to void frequently, hesitancy, weak stream, and other problems, and can cause acute urinary retention requiring immediate medical attention.
A 51-year-old woman, with no significant previous medical history, was admitted with acute urinary retention.
Avodart is approved for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms, reduce the risk of acute urinary retention (AUR), and reduce the risk of the need for BPH-related surgery In combination with the alpha-blocker tamsulosin, Avodart is also approved for the treatment of symptomatic BPH in men with an enlarged prostate.
Although finasteride is less effective in reducing lower urinary tract symptoms than are [alpha]-antagonists, it does reduce the risk of acute urinary retention and the need for surgery for BPH.
3] BPH can manifest itself through LUTS and, if left untreated, can lead to complications, such as acute urinary retention (AUR), BPH-related surgery, incontinence, recurrent urinary tract infections and, in some cases, renal failure.

Full browser ?